Pre-screening before ...
Published by Yuri Obst, Founder & Acting CEO at Baleen Filters Pty Limited
Pre-screening before biological treatment to around 100-microns for removal of non-soluble BOD/COD, followed by secondary micro-screening for residual removal of non-soluble BOD/COD. More information available at www.baleen.com